Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - ACCELLENT INC | d354613d8k.htm |
Exhibit 99.1
Investor Contact: Jeremy Friedman
Executive Vice President and Chief Financial Officer
978 570 6900
Jeremy.friedman@accellent.com
FOR IMMEDIATE RELEASE
Accellent Inc. Announces First Quarter 2012 Results
Wilmington, MA (May 14, 2012) – Accellent Inc. (the “Company” or “Accellent”), a wholly owned subsidiary of Accellent Holdings Corp., today announced results for its fiscal first quarter ended March 31, 2012.
First Quarter 2012 Financial Results
Net sales increased 1.3% to $131.6 million in the first quarter of 2012 compared with $129.9 million in the first quarter of 2011. Income from operations was $11.0 million in the first quarter of 2012, compared with $13.0 million in the first quarter of 2011. Net loss was $7.0 million in the first quarter of 2012, compared with a net loss of $8.2 million in the first quarter of 2011.
Adjusted EBITDA for the first quarter of 2012 was $23.0 million, or 17.5% of net sales, compared to Adjusted EBITDA of $23.8 million, or 18.4% of net sales, in the first quarter of 2011.
“We returned to year over year top-line growth in the first quarter, despite a continued soft market,” stated Donald Spence, President and CEO of Accellent. “Revenue increased 1.3% in the first quarter; however our profitability declined compared to last year. I remain optimistic that we are creating the necessary changes in our business to succeed both in today’s challenging market and also in the long-term.”
Reconciliations of non-GAAP financial measures to GAAP financial measures are provided in the financial information accompanying this press release.
Conference Call
Donald Spence, President and Chief Executive Officer, and Jeremy A. Friedman, Executive Vice President and Chief Financial Officer, will discuss our first quarter financial results in a conference call scheduled for today, May 14, 2012 at 5 p.m. Eastern Standard Time. The teleconference can be accessed live on the Internet through the Investor Relations section of the Accellent website at www.accellent.com or by calling (866) 804-6928 pass code 88571031. Please visit the website or dial in 10 to 15 minutes prior to the beginning of the call to download and install any necessary audio software. A replay of the conference call will be available via www.accellent.com or by telephone at (888) 286-8010 pass code 35531841 until May 21, 2012.
About Accellent
Accellent Holdings Corp., through its wholly owned subsidiary Accellent, Inc., provides fully integrated outsourced manufacturing and engineering services to the medical device industry primarily in the cardiology, endoscopy and orthopedic markets. Accellent has broad capabilities in precision component fabrication, finished device assembly, complete supply chain management capabilities and engineering services. These capabilities enhance customers’ speed to market and return on investment by enabling them to refocus internal resources more efficiently. For more information, please visit www.accellent.com.
Forward-Looking Statements
This press release includes “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended. All statements included herein, other than statements of historical fact, may constitute forward-looking statements. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct. Important factors that could cause actual results to differ materially from the Company’s expectations are disclosed in the risk factors contained in the Company’s Form 10-K for the year ended December 31, 2011 filed with the Securities and Exchange Commission on March 29, 2012. All forward-looking statements are expressly qualified in their entirety by such risk factors.
ACCELLENT INC.
Unaudited Condensed Consolidated Statements of Operations
(in thousands)
| Three Months Ended | ||||||||
| March 31, 2011 |
March 31, 2012 |
|||||||
| Net sales |
$ | 129,889 | $ | 131,578 | ||||
| Cost of sales (exclusive of amortization) |
98,318 | 100,967 | ||||||
|
|
|
|
|
|||||
| Gross profit |
31,571 | 30,611 | ||||||
|
|
|
|
|
|||||
| Operating expenses: |
||||||||
| Selling, general and administrative expenses |
14,112 | 15,050 | ||||||
| Research and development expenses |
747 | 474 | ||||||
| Restructuring charges |
— | 353 | ||||||
| Gain on disposal of property and equipment |
— | (1 | ) | |||||
| Amortization of intangible assets |
3,735 | 3,735 | ||||||
|
|
|
|
|
|||||
| Total operating expenses |
18,594 | 19,611 | ||||||
|
|
|
|
|
|||||
| Income from operations |
12,977 | 11,000 | ||||||
|
|
|
|
|
|||||
| Other (expense) income, net: |
||||||||
| Interest expense, net |
(17,249 | ) | (17,242 | ) | ||||
| Other (expense) income, net |
(1,934 | ) | 178 | |||||
|
|
|
|
|
|||||
| Total other (expense) income, net |
(19,183 | ) | (17,064 | ) | ||||
|
|
|
|
|
|||||
| Loss before income taxes |
(6,206 | ) | (6,064 | ) | ||||
| Provision for income taxes |
1,965 | 922 | ||||||
|
|
|
|
|
|||||
| Net loss |
$ | (8,171 | ) | $ | (6,986 | ) | ||
|
|
|
|
|
|||||
ACCELLENT INC.
Unaudited Condensed Consolidated Balance Sheets
(in thousands)
| December 31, 2011 |
March 31, 2012 |
|||||||
| Assets |
||||||||
| Current assets: |
||||||||
| Cash |
$ | 38,858 | $ | 35,149 | ||||
| Accounts receivable, net |
54,763 | 62,023 | ||||||
| Inventory |
65,962 | 71,193 | ||||||
| Prepaid expenses and other current assets |
4,481 | 5,277 | ||||||
|
|
|
|
|
|||||
| Total current assets |
164,064 | 173,642 | ||||||
| Property, plant and equipment, net |
126,992 | 124,563 | ||||||
| Goodwill |
629,854 | 629,854 | ||||||
| Other intangible assets, net |
149,687 | 145,952 | ||||||
| Deferred financing costs and other assets, net |
16,825 | 16,195 | ||||||
|
|
|
|
|
|||||
| Total assets |
$ | 1,087,422 | $ | 1,090,206 | ||||
|
|
|
|
|
|||||
| Liabilities and Stockholder’s equity |
||||||||
| Current liabilities: |
||||||||
| Current portion of long-term debt |
$ | 22 | $ | 22 | ||||
| Accounts payable |
22,580 | 27,142 | ||||||
| Accrued expenses and other current liabilities |
46,487 | 50,237 | ||||||
|
|
|
|
|
|||||
| Total current liabilities |
69,089 | 77,401 | ||||||
| Long-term debt |
712,967 | 713,042 | ||||||
| Other long-term liabilities |
38,466 | 39,085 | ||||||
|
|
|
|
|
|||||
| Total liabilities |
820,522 | 829,528 | ||||||
| Stockholder’s equity |
266,900 | 260,678 | ||||||
|
|
|
|
|
|||||
| Total liabilities and stockholder’s equity |
$ | 1,087,422 | $ | 1,090,206 | ||||
|
|
|
|
|
|||||
ACCELLENT INC.
Reconciliation of Net Loss to EBITDA to Adjusted EBITDA
(in thousands)
| Three Months Ended | ||||||||
| March 31, 2011 |
March 31, 2012 |
|||||||
| Net loss |
$ | (8,171 | ) | $ | (6,986 | ) | ||
| Interest expense, net |
17,249 | 17,242 | ||||||
| Provision for income taxes |
1,965 | 922 | ||||||
| Depreciation and amortization |
9,441 | 10,083 | ||||||
|
|
|
|
|
|||||
| EBITDA (1) |
$ | 20,484 | $ | 21,261 | ||||
| Adjustments: |
||||||||
| Stock-based compensation – employees |
248 | 40 | ||||||
| Stock-based compensation – non-employees |
23 | 23 | ||||||
| Employee severance and relocation |
335 | 814 | ||||||
| Restructuring charges |
— | 353 | ||||||
| Executive recruiting costs |
221 | — | ||||||
| Plant closure costs and other |
— | 169 | ||||||
| Currency loss (gain) |
2,020 | (185 | ) | |||||
| Gain on disposal of property and equipment |
— | (1 | ) | |||||
| Franchise and other taxes |
190 | 205 | ||||||
| Management fees to stockholder |
319 | 335 | ||||||
|
|
|
|
|
|||||
| Adjusted EBITDA (1) |
$ | 23,840 | $ | 23,014 | ||||
|
|
|
|
|
|||||
| (1) | EBITDA and Adjusted EBITDA presented in this press release are supplemental measures of our performance that are not required by, or presented in accordance with, GAAP. EBITDA and Adjusted EBITDA are not measurements of our financial performance under GAAP and should not be considered as alternatives to net income (loss) or any other performance measures derived in accordance with GAAP, or as an alternative to cash flow from operating activities as a measure of our liquidity. |
EBITDA represents net income (loss) before net interest expense, provision for income taxes and depreciation and amortization. Adjusted EBITDA represents EBITDA further adjusted to give effect to certain non-cash items and other adjustments, all of which are defined in the indentures governing our debt. The adjustments include adjustments for restructuring charges and related plant closure costs, stock compensation charges, severance and relocation costs, executive recruiting costs, currency gains and losses, gains and losses on derivative instruments, gains and losses resulting from the disposal of property and equipment, certain non-income based taxes, losses on debt extinguishment, and management fees.
We believe that the presentation of EBITDA and Adjusted EBITDA is appropriate to provide as additional information for investors. We consider it an important supplemental measure of our performance and we believe that both are frequently used by securities analysts, investors and other interested parties in the evaluation of high yield issuers.